Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-18
DOI
10.1186/s13195-020-00596-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease
- (2019) Joana R. F. Santos et al. JOURNAL OF NEURAL TRANSMISSION
- Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer’s Disease
- (2019) Nicolas R. Barthélemy et al. Frontiers in Aging Neuroscience
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- 2018 Alzheimer's disease facts and figures
- (2018) Alzheimers & Dementia
- Alzheimer’s Disease: Advances in Drug Development
- (2018) Morgane Piton et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
- (2018) Yan Zhou et al. Frontiers in Aging Neuroscience
- Impact of the 2008–2012 French Alzheimer Plan on the Use of Cerebrospinal Fluid Biomarkers in Research Memory Center: The PLM Study
- (2018) Audrey Gabelle et al. JOURNAL OF ALZHEIMERS DISEASE
- Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation
- (2018) Alessia Lasorsa et al. Frontiers in Molecular Neuroscience
- FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease
- (2016) Waltraud Mair et al. ANALYTICAL CHEMISTRY
- Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
- (2016) Nicolas R Barthélemy et al. JOURNAL OF PROTEOME RESEARCH
- The influence of cerebrospinal fluid (CSF) biomarkers on clinical dementia evaluations
- (2015) Jonathan Gooblar et al. Alzheimers & Dementia
- Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic
- (2015) Flora H. Duits et al. Alzheimers & Dementia
- CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study
- (2015) Michael Ewers et al. Alzheimers & Dementia
- Age and amyloid effects on human central nervous system amyloid-beta kinetics
- (2015) Bruce W. Patterson et al. ANNALS OF NEUROLOGY
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins
- (2014) Eric B. Dammer et al. PROTEOMICS
- A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
- (2014) Sylvain Lehmann et al. Alzheimers Research & Therapy
- Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study
- (2013) François Mouton-Liger et al. JOURNAL OF NEUROLOGY
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- The Importance of Tau Phosphorylation for Neurodegenerative Diseases
- (2013) Wendy Noble et al. Frontiers in Neurology
- Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting
- (2012) Julien Dumurgier et al. Alzheimers & Dementia
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Shapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease
- (2012) Clifford R. Jack et al. ARCHIVES OF NEUROLOGY
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
- (2011) N. S. M. Schoonenboom et al. NEUROLOGY
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GSK3: A possible link between beta amyloid peptide and tau protein
- (2009) Félix Hernández et al. EXPERIMENTAL NEUROLOGY
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- Biochemistry of Tau in Alzheimer’s disease and related neurological disorders
- (2008) Nicolas Sergeant et al. Expert Review of Proteomics
- Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
- (2007) B. Borroni et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now